ALTEN Calsoft Labs launches blockchain clinical trial platform in partnership with clinical research organisation Clinlogix
Deep Lens, an AI-enabled clinical trial recruitment platform, has closed a $14 million Series A round led by Northpond Ventures, with participation from existing investors Rev1 Ventures, Sierra Ventures, and Tamarind-Hill Partners.
TriNetX, a clinical research network, has closed its Series D investment round of $40 million led by Merck GHIF. The funding will be used for international expansion and product development.
The Gustave Roussy Institut, a cancer centre in France, is to deploy blockchain in data-sharing applications for oncology research. The technology will be built in partnership with Embleema, a developer of a healthcare blockchain network, and will be used to improve transparency, patient safety and patient engagement in clinical trials.
AI drug trials to scale up in 2019
Predictions are two a penny at this time of year, and no one will hold those who make the predictions to account. Tractica, a market intelligence agency, has put out a white paper with predictions on Artificial Intelligence in 2019. Amongst them is an expectation of advancement in AI-enabled drug trials.Alex Guest Tue, 01/01/2019 - 13:46